Gepefrine

Gepefrine

Molecular structure via molpic based on CDK

Rotamer []

Conformer structure via 3Dmol.js

Physical properties []
Molecular mass	151.21 g/mol ^[1]
Predicted LogP	1.4 ^[1]

Structural Identifiers []
Molecular formula	C₉H₁₃NO ^[1]
IUPAC name	3-[(2S)-2-aminopropyl]phenol ^[1]
SMILES	C[C@@H](CC1=CC(=CC=C1)O)N ^[1]
InChI	InChI=1S/C9H13NO/c1-7(10)5-8-3-2-4-9(11)6-8/h2-4,6-7,11H,5,10H2,1H3/t7-/m0/s1 ^[1]
InChIKey	WTDGMHYYGNJEKQ-ZETCQYMHSA-N ^[1]

Gepefrine (also known as gepefrina, Gepefrin, Dtxsid60172191, α-Methyl-m-tyramine, gepefrinum, 3-hydroxyamphetamine, α-methyl-meta-tyramine, Dtxcid7094682, C01CA15 or 3-(2-Aminopropyl)phenol) is a sympathomimetic substance of the amphetamine class.

Chemistry

Stereochemistry []

Gepefrine is a absolute mixture.

Pharmacology

ATC Classification

In the cardiovascular system (C) gepefrine acts

Metabolism

Subjective effects []

class / Sympathomimetic

Physical effects
Abnormal heartbeat Dehydration Dry mouth Increased blood pressure Increased heart rate Restless legs Shakiness Stamina enhancement Vasoconstriction

Cognitive effects
Thought acceleration Wakefulness

External links []

References []

National Center for Biotechnology Information. PubChem Compound Summary for CID 219105, Gepefrine. Accessed May 6, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/219105
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Gepefrine. UNII: V51RRX51VH. Global Substance Registration System. Accessed May 6, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/V51RRX51VH

AnodyneWiki